Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Qiagen GmbH
Qiagen GmbH
Activities:
Manufacturing
Research & Development
Analysis
Medical Devices
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Finance
Qiagen introduces cloud-based product selection application
The Workflow Configurator allows customers to choose from a variety of products per workflow step, as well as save, share and purchase their bespoke product configuration
Manufacturing
Tecan and Qiagen collaborate on automation in blood analysis
The device is aimed to reduce the risk of operators coming into contact with infectious materials and save time
Research & Development
Qiagen enters agreement with precision diagnostics company
The German company has received an exclusive license to use Ares Genetics’s database and toolbox, to develop bioinformatics and assays for antimicrobial resistance research
Analysis
Qiagen invests in Digital PCR machines
Fully integrated Digital PCR machines will be in use by 2020 at Qiagen
Media
Protein purification and isolation market worth US$6370m by 2020
The market is growing due to increased R&D, as well as demand for ligand ID and rapid purification kits
Ingredients
Qiagen acquires Enzyme Solutions Unit of Enzymatics
Now able to offer a complete next-generation sequencing workflow from biological sample to molecular insights
You need to be a subscriber to read this article.
Click here
to find out more.
Regulatory
Reimbursment issues hinder future development of personal therapies
The development of more targeted therapies is moving apace, but are the payers prepared for it? Dr Sarah Houlton looks at the progress of personalised medicines
Subscribe now